Psilocybin and Spiritual Healing: When Meaning Returns
There are moments in life when the ground beneath us disappears. A diagnosis. A loss. A quiet realization that the future we imagined is no longer guaranteed. In these moments, suffering is not only physical or emotional—it is existential.
What Is Spiritual Healing, Really?
Spiritual healing is not about adopting a belief system.
It is about reorienting your relationship to existence itself.
People often describe it as:
A sense of connection (to others, nature, or something larger)
A softening of fear around death
A felt sense that life still has meaning, even in uncertainty
A shift from “Why me?” to “How do I live this?”
Psilocybin does not “give” these insights.
It appears to create conditions where they can emerge.
What the Research Suggests
Modern clinical research has begun to explore something long observed in spiritual traditions:
Certain experiences—often described as mystical or transcendent—can lead to lasting psychological and spiritual change.
In controlled settings:
Psilocybin has been shown to produce mystical-type experiences associated with deep personal meaning and spiritual significance
Many participants rate these experiences among the most meaningful of their lives, with lasting changes in mood, behavior, and perspective
In cancer patients, psilocybin-assisted therapy has led to substantial and sustained reductions in depression and anxiety, alongside improvements in existential distress and quality of life
These improvements are often linked to increases in meaning, connectedness, and spiritual well-being
One of the most important findings:
It’s not just the drug—it’s the experience itself, especially when it includes a sense of unity, awe, or transcendence, that predicts lasting healing
SACHI’S TAKE
Spiritual healing isn’t just about becoming someone new. And it’s not simply about returning to who you were.
For many people, it’s both.
There can be a sense of remembering something familiar—
a way of relating to life that feels more open, more connected. And at the same time, something has changed.
You are not the same person you were before.
Common Questions about Psilocybin and Spirituality
Is psilocybin a form of spiritual healing?
Not inherently. Some people report spiritual or meaningful experiences during psilocybin sessions, but outcomes vary and depend heavily on context, preparation, and integration.
Can psilocybin reduce fear of death?
Some studies suggest reductions in death anxiety, especially in structured therapeutic settings. However, this is not universal and should not be assumed.
Do you have to be spiritual for this to work?
No. People with a wide range of beliefs—including none—have reported meaningful experiences. Interpretation varies.
Is one session enough?
In some studies, a single session has led to lasting effects, but integration and support afterward are critical.
Is this legal?
It depends on location. Some jurisdictions allow supervised use; many do not.
SACHI’S TAKE
For some people, the word spirituality feels meaningful, comforting, and expansive. For others, it sounds vague, sentimental, or even cringe. That is okay. We do not need everyone to use the same language.
A scientifically minded person might prefer words like awe, connection, openness, transcendence, presence, meaning, love, humility, or self-transcendence. These words may feel more grounded, but they often point toward a similar human experience: the sense that life is larger than our ordinary worries, roles, defenses, and routines.
At Sachi, we do not believe spirituality requires abandoning critical thinking. In fact, the opposite may be true. The most meaningful experiences are often held best with both openness and discernment. You can stay thoughtful, skeptical, and grounded while also allowing yourself to be moved.
Continue Learning from Sachi
Introduction to psilocybin
Whether you are well-versed in psychedelic medicine, or you just watched your first documentary (How To Change Your Mind on Netflix is fantastic!), science has been advancing knowledge about psilocybin and psychedelics for decades.
What are psychedelics? Psilocybin?
We went to the web to help explain:
Psychedelics are powerful psychoactive substances that alter perception and mood and affect numerous cognitive processes. They are generally considered physiologically safe and do not lead to dependence or addiction. Their origin predates written history, and they were employed by early cultures in many sociocultural and ritual contexts.
Introduction of a 2016 Pharmacology Reviews article
Psychedelics are a class of drugs that produce changes in mood, perception, and cognitive processes. There is a growing body of research showing that psychedelics, often when combined with therapy, can help to treat challenging mental health conditions.
Our friends at Numinus
Psilocybin is a compound in psychedelic fungi, which are also known as “magic mushrooms” or “shrooms.” Studies have shown that psilocybin-assisted therapy can be an effective treatment for conditions including depression, anxiety, and eating disorders. Psilocybin is illegal in most U.S. jurisdictions, but has been decriminalized in 15 cities and states. The use of psilocybin by indigenous cultures has been documented dating back 6,000 years.
Our friends at Lucid News
SACHI’S TAKE
Psilocybin (magic mushrooms) entered the mainstream narrative in the 1960s. Yes, this is the same molecule from pop culture books, movies, and TV shows. Starting in the 1950s, researchers have explored its potential medical benefits. Psilocybin and other psychedelics were heavily researched through the 1970s, with promising results. Unfortunately, research was restricted during the Nixon Administration’s War on Drugs, when they were classified as a Schedule I substance.
Thankfully, research slowly resumed, and in the last 30 years has produced amazing evidence about the benefits of psilocybin across many disease states. These positive results have ushered in a new era of awareness and advocacy, with several FDA psychedelic approvals expected in the next few years.
We are in the middle of the psychedelic renaissance. Learn more about the rich history of scientific research with psilocybin.
Psilocybin is becoming more accessible across the US.
While the US government classifies psilocybin and other psychedelics as Schedule 1 drugs, there has been a gradual easing of restrictions based on individual state interpretation.
- Oregon (2020) and Colorado (2022) were the first US states to legalize the use of psilocybin.
- New Mexico (2025) just legalized psilocybin as well.
- As of April 2025, 30 states were investigating legislative options for access to psychedelics for mental health, including California, Illinois, Michigan, Wisconsin, and Pennsylvania.
For a great visual tracker of psychedelic policy and reform across the US, check out
Psychedelic Alpha’s Tracker.
Psilocybin research has accelerated and launched a new wave of discovery.
Based on the research of the 1950s and 60s, research has restarted into the clinical and medical benefits of psychedelics for many medical specialties. Research is underway to evaluate the use of psychedelics for diseases including: post traumatic stress disorder, depression, anxiety, end of life distress, addiction, trauma, chronic pain, and migraine headaches.
Psilocybin research and clinical trials are paving the way for legal and regulatory acceptance.
Based on growing scientific proof, industry experts believe we are in a “psychedelic renaissance”. There is optimism that psychedelics will receive FDA clearance for specific indications in the next few years for:
- Psilocybin for the psychological distress of cancer
- Psilocybin for PTSD
- Psilocybin for Major Depressive Disorder
- MDMA for PTSD
What does psilocybin do? How does it affect us?
Psilocybin is a well researched and understood compound, with use dating back to ancient civilizations. Its effects have been studied at the biological level, with modern science helping us understand its short and long term effects. Learn more about its effects.
Continue Learning from Sachi
2023 TIME magazine article about two different psychedelics (MDMA and psilocybin) and their potential upcoming approvals
A great overview article from 2021 about psilocybin regulation and move toward decriminalization (note: heavy legal language included)
In 2021, the most read and discussed
JAMA article highlighted the benefits of psilocybin for patients with Major Depressive Disorder. This Johns Hopkins-led study showed immediate benefit and benefit to 4 weeks for psilocybin as part of psychedelic-assisted therapy.
Dr. Andrew Huberman’s
podcast episode about psilocybin—very in-depth with a neurobiology focus
Tim Ferriss has a great introduction to psychedelics on his
Psychedelic 101 website.
From
clinicaltrials.gov, in April 2024, there were 182 listed trials involving Psilocybin, with 14 trials focused on cancer.
The Multidisciplinary Association for Psychedelic Studies (MAPS) offers a great
psychedelic fundamentals course (note there is a small one-time cost).
For clinicians or health practitioners, there are many education resources available—our friends at the
Psychedelic Medical Association have some great free resources to get you started on their
psilocybin page.